Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu

Related-Donor Bone Marrow Transplant at URMC

Research Question:
What is the safety and validity of the process for related donor haploidentical stem cell transplantation at the Wilmot Cancer Institute Blood and Marrow Transplant Unit?

Basic Study Information

Purpose:
This study will be a single-center treatment protocol with five possible preparative regimens, designed to validate the process of related donor haploidentical stem cell transplantation at the Wilmot Cancer Institute Blood and Marrow Transplant Unit. Enrolled patients will receive chemotherapy +/- radiation as a pre-transplant conditioning regimen. Patients will then receive haploidentical stem cells, either bone marrow or mobilized peripheral blood, followed by GvHD prophylaxis that will include cyclophosphamide. Multiple data points will be collected prior to, during, and following transplantation to ensure safety of the process and to evaluate the stated objectives.

Location: University of Rochester Medical Center
Study Reference #: UBMT15056-

Lead Researcher (Principal Investigator)

Lead Researcher:  Jeffrey Andolina

Study Contact Information

Study Coordinator: katherine Nedrow
Phone: (585) 275-3893
Email: Katherine_Nedrow@URMC.Rochester.edu

Additional Study Details

Return to Search